← Eichor
Study identifier: NCT00001276 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Diagnosing and Treating Low Blood Sugar Levels

Condition: Hypoglycemia · Insulinoma  ·  Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

PhaseN/A
Planned participants1500
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

About this study

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.

This description comes directly from the study's public registry record.

Talk to the study team

Craig S Cochran, R.N.  ·  (301) 402-1880  ·  craigc@bdg10.niddk.nih.gov

Ranganath Muniyappa, M.D.  ·  (301) 451-7702  ·  muniyapr@mail.nih.gov

Always discuss trial participation with your own doctor first.

Locations (1)

National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00001276